Marine natural products comprise unique chemical structures and vast varieties of biological activities. This review aims to summarize halichondrin, a marine natural product, and its synthetic analogs along with its therapeutic properties and mechanisms. Halichondrin and its analogs, derived from marine sponges, exhibit potent antineoplastic properties, making them promising candidates for cancer therapeutics. These compounds, characterized by their complex molecular structures, have demonstrated significant efficacy in inhibiting microtubule dynamics, leading to cell cycle arrest and apoptosis in various cancer cell lines. Several types of halichondrins such as halichondrins B, C, norhalichondrin B, and homohalichondrin B have been discovered with similar anticancer and antitumor characteristics. Since naturally available halichondrins show hurdles in synthesis, recent advancements in synthetic methodologies have enabled the development of several halichondrin analogs, such as E7389 (eribulin), which have shown improved therapeutic indices. Eribulin has shown excellent immunomodulatory properties by several mechanisms such as reprogramming tumor microenvironments, facilitating the infiltration and activation of immune cells, and inhibiting microtubule dynamics. Despite promising results, challenges remain in the synthesis and clinical application of these compounds. This review explores the mechanisms underlying the immunomodulatory activity of halichondrin and its analogs in cancer therapy, along with their clinical applications and potential for future drug development.

Muscle atrophy is a detrimental and injurious condition that leads to reduced skeletal muscle mass and disruption of protein metabolism. Oyster (Crassostrea nippona) is a famous and commonly consumed shellfish in East Asia and has become a popular dietary choice worldwide. The current investigation evaluated the efficacy of C. nippona against muscle atrophy, which has become a severe health issue. Mammalian skeletal muscles are primarily responsible for efficient metabolism, energy consumption, and body movements. The proteins that regulate muscle hypertrophy and atrophy are involved in muscle growth. C. nippona extracts were enzymatically hydrolyzed using alcalase (AOH), flavourzyme (FOH), and protamex (POH) to evaluate their efficacy in mitigating dexamethasone-induced muscle damage in C2C12 cells in vitro. AOH exhibited notable cell proliferative abilities, promoting dose-dependent myotube formation. These results were further solidified by protein expression analysis. Western blot and gene expression analysis via RT-qPCR demonstrated that AOH downregulated MuRF-1, Atrogin, Smad 2/3, and Foxo-3a, while upregulating myogenin, MyoD, myosin heavy chain expression, and mTOR, key components of the ubiquitin–proteasome and mTOR signaling pathways. Finally, this study suggests that AOH holds promise for alleviating dexamethasone-induced muscle atrophy in C2C12 cells in vitro, offering insights for developing functional foods targeting conditions akin to sarcopenia.

Due to large-scale macroalgal blooms, nutrient enrichment, and changes in ocean circulation brought on by climate change, beach-accumulated seaweed (BAS) has quickly become a global environmental and waste-governance concern. Despite degradation and contamination during beach stranding, BAS retains valuable bioactive compounds, including sulfated polysaccharides, phlorotannins, pigments, proteins, peptides, and lipids, which exhibit anti-inflammatory, antioxidant, antimicrobial, antiviral, immunomodulatory, anticancer, and metabolic regulatory activities. This review critically evaluates BAS as a sustainable bioresource by integrating current knowledge on biomass composition, degradation-associated challenges, bioactive properties, valorization pathways, advanced extraction technologies, safety validation, regulatory considerations, and emerging commercialization opportunities. Attention is given to sustainable valorization pathways, ranging from composting and bioenergy production to the recovery of high-value bioactives through enzyme-assisted, green, and advanced extraction technologies. The review further discusses policy and regulatory gaps, contamination challenges, safety validation requirements, and life-cycle sustainability considerations that currently limit industrial adoption. Finally, emerging opportunities involving metabolomics, microbial bioprocessing, artificial intelligence, automation, and nanotechnology are explored as future directions for transforming BAS into a standardized and economically viable feedstock within the circular blue bioeconomy. Establishing harmonized regulatory frameworks and integrating BAS management with Sustainable Development Goals (SDGs) 12 and 14 will be critical for enabling sustainable resource recovery and long-term coastal resilience.

The seafood processing industry generates significant amounts of solid waste, including boiled tuna skin, a major byproduct with limited commercial use. Antioxidant activities of Flavourzyme hydrolysate derived from boiled Skipjack tuna (Katsuwonus pelamis) skin byproduct were assessed for their ability to reduce AAPH-induced oxidative stress in In Vitro and In Vivo. The functional properties were improved by enzymatic hydrolysis with Flavourzyme at pH 7.0 to produce an antioxidant hydrolysate. Antioxidant activity was evaluated for boiled tuna skin Flavourzyme hydrolysate (BTSFH) using Hydrogen Peroxide Scavenging activity and ABTS radical scavenging activity. The IC₅₀ values for H₂O₂ and ABTS radical-scavenging activities were 2.91 mg/mL and 7.52 mg/mL. BTSFH treatment increased cell viability, significantly reduced ROS production under AAPH-induced oxidative stress, and protected against AAPH-induced apoptotic DNA damage. BTSFH exhibited potent antioxidant activity by upregulating endogenous antioxidant enzymes (SOD and Catalase) in AAPH- stimulated Vero cells. An in vivo zebrafish assay demonstrated its antioxidant potential effects by reducing ROS generation, lipid peroxidation, and cell death, thereby supporting its potential as a bioactive compound. These in vitro and in vivo studies’ findings showed that the BTSFH sample represented strong antioxidant activity, making it preliminary evidence for use in pharmaceuticals and health supplements. Marine byproducts as a source of functional ingredients help reduce waste and promote better resource management, aligning with broader goals for a more sustainable circular bioeconomy.